ArticleDiagnostics (Basel, Switzerland)2022

Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment-Results from the GISTAR Pilot Study.

Claudia Robles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.